GSK3B and hepatocellular carcinoma: It is known that the downregulation of WWOX leads to cytoplasmic β-catenin accumulation and the subsequent activation of the Wnt/β-catenin signaling pathway in HCC [4], while decreases in the activities of Akt and GSK-3β inhibit the expression of β-catenin.